IRVING, TEXAS— Ontada®, a McKesson business focused on oncology provider technology solutions, targeted channels for biopharmaceutical and provider engagement, and a research arm focused on clinical data and evidence solutions, announced the promotion of Nicholas Robert, M.D., to the role of Chief Medical Officer (CMO) and member of the Ontada leadership team.
In this newly created role, Dr. Robert will be responsible for deepening Ontada’s clinical focus and expertise. As the senior clinical leader at Ontada, Dr. Robert will collaborate across the organization to ensure studies, real-world data offerings and educational programs maintain the highest scientific standards and clinical relevance. He will also collaborate with physicians and physician-led groups, including The US Oncology Network (The Network), to support a broad range of clinical initiatives for cancer physicians, nurses, pharmacists, and other care team members.
“Dr. Robert has a long history in cancer research as the author of more than 100 publications and a leader in community oncology and The Network.,” said Susan Shiff, President of Ontada. “I am thrilled with the experience and compassion Dr. Robert will bring to his new role as Ontada Chief Medical Officer.”
In his most recent role, Dr. Robert served as Vice President, Medical Affairs Ontada, where he oversaw the development and completion of real-world evidence studies, including the MYLUNG Consortium™ Protocol 1. Much of his career has been spent as a practicing physician, including as Medical Director, Virginia Cancer Specialists research program and Clinical Director, Medical Oncology, Tufts Medical Center. Dr. Robert received his medical degree from McGill Medical School and completed residencies at Royal Victoria Hospital and Massachusetts General Hospital and a fellowship at Brigham and Women’s Hospital and Dana Farber Cancer Institute. He was fellow at Harvard Medical School.
Dr. Robert also serves as a reviewer for medical journals, including the Journal of Clinical Oncology-Clinical Cancer Informatics. He is a member of several industry organizations, including the American Society of Clinical Oncology (ASCO), and is board certified in Internal Medicine, Anatomic Pathology, Medical Oncology, and Hematology.
“Ontada is in a unique position to harness the power of real-world evidence to develop insights that impact patient outcomes and quality of cancer care,” said Dr. Robert. “I’m honored to accept this new role and lead Ontada’s clinical team working with our physicians and their oncology teams as we help transform the fight against cancer.”
Ontada® is an oncology real-world data and evidence, clinical education and provider technology business dedicated to transforming the fight against cancer. Part of McKesson Corporation, we support science through our data, technology and channels, which accelerate innovation for life science companies, support the education of community oncology providers and advance patient care. Together with our partners, we improve the lives of cancer patients. For more information, visit ontada.com or follow @OntadaOncology.
General and Business Press
Ryan Mathre, External Communications